Bromoallenes as allyl dication equivalents in the absence of palladium(0): Synthesis of bicyclic sulfamides by tandem cyclization of bromoallenes

Angewandte Chemie - International Edition

Volumn 44, Issue 10, 2005, Pages 1513-1517

  Hamaguchi, Hisao ^a   Kosaka, Shohei ^a   Ohno, Hiroaki ^a   Tanaka, Tetsuaki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Allenes; Cyclization; Halogen compounds; Palladium; Sulfamides

Indexed keywords

ATOMS; CARBON; NITROGEN; PALLADIUM COMPOUNDS; SULFAMIC ACID; SYNTHESIS (CHEMICAL);

ALLENIC MOIETY; CARBON ATOMS; INTRAMOLECULAR NUCLEOPHILIC ATTACK; NITROGEN ATOMS;

BROMINE COMPOUNDS;

ALLENE DERIVATIVE; BICYCLIC SULFAMIDE; BICYCLO COMPOUND; BROMINE DERIVATIVE; BROMOALLENE; CATION; HETEROCYCLIC COMPOUND; METHANOL; N,N DIMETHYLFORMAMIDE; PALLADIUM; SOLVENT; SULFONAMIDE; TETRAHYDROFURAN; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYST; CYCLIZATION; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; ROOM TEMPERATURE;

BROMINE COMPOUNDS; CYCLIZATION; PALLADIUM; SPECTRUM ANALYSIS; SULFONAMIDES;

EID: 16244407181     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200462557     Document Type: Article

References (46)

1. S. Ma, in Modern Allene Chemistry, Vol. 2 (Eds.: N. Krause, A. S. K. Hashmi), Wiley-VCH, Weinheim, 2004, pp. 614-619.
2. a) H. Ohno, H. Hamaguchi, T. Tanaka, Org. Lett. 2001, 3, 2269-2271;
3. b) H. Ohno, K. Ando, H. Hamaguchi, Y. Takeoka, T. Tanaka, J. Am. Chem. Soc. 2002, 124, 15 255-15 266.
4. a) H. Ohno, H. Hamaguchi, M. Ohata, T. Tanaka, Angew. Chem. 2003, 115, 1791-1795; Angew. Chem. Int. Ed. 2003, 42, 1749-1753;
5. a) H. Ohno, H. Hamaguchi, M. Ohata, T. Tanaka, Angew. Chem. 2003, 115, 1791-1795; Angew. Chem. Int. Ed. 2003, 42, 1749-1753;
6. b) H. Ohno, H. Hamaguchi, M. Ohata, S. Kosaka, T. Tanaka, Heterocycles 2003, 61, 65-68;
7. c) H. Ohno, H. Hamaguchi, M. Ohata, S. Kosaka, T. Tanaka, J. Am. Chem. Soc. 2004, 126, 8744-8754.
8. a) E. J. Corey, N. W. Boaz, Tetrahedron Lett. 1984, 25, 3059-3062;
9. b) A. M. Caporusso, C. Polizzi, L. Lardicci, Tetrahedron Lett. 1987, 28, 6073-6076;
10. c) F. D'Aniello, A. Mann, A. Schoenfelder, M. Taddei, Tetrahedron 1997, 53, 1447-1456;
11. d) F. Chemla, N. Bernard, J. Normant, Eur. J. Org. Chem. 1999, 2067-2078;
12. e) J. J. Conde, W. Mendelson, Tetrahedron Lett. 2000, 41, 811-814;
13. f) A. M. Caporusso, S. Filippi, F. Barontini, P. Salvadori, Tetrahedron Lett. 2000, 41, 1227-1230.
14. a) G. Märkl, P. Attenberger, J. Kellner, Tetrahedron Lett. 1988, 29, 3651-3654;
15. b) T. Gillmann, T. Hülsen, W. Massa, S. Wocadlo, Synlett 1995, 1257-1259;
16. c) R. W. Saalfrank, M. Haubner, C. Deutscher, W. Bauer, T. Clark, J. Org. Chem. 1999, 64, 6166-6168.
17. a) J. A. Marshall, N. D. Adams, J. Org. Chem. 1997, 62, 8976-8977;
18. b) S. Ma, S. Yu, S. Yin, J. Org. Chem. 2003, 68, 8996-9002.
19. a) J. Hultén, N. M. Bonham, U. Nillroth, T. Hansson, G. Zuccarello, A. Bouzide, J. Åqvist, B. Classon, U. H. Danielson, A. Karlén, I. Kvarnström, B. Samuelsson, A. Hallberg, J. Med. Chem. 1997, 40, 885-897;
20. b) K. Bäckbro, S. Löwgren, K. Österlund, J. Atepo, T. Unge, J. Hultén, N. M. Bonham, W. Schaal, A. Karlén, A. Hallberg, J. Med. Chem. 1997, 40, 898-902;
21. c) J. Hultén, H. O. Andersson, W. Schaal, U. H. Danielson, B. Classon, I. Kvarnström, A. Karlén, T. Unge, B. Samuelsson, A. Hallberg, J. Med. Chem. 1999, 42, 4054-4061;
22. d) W. Schaal, A. Karlsson, G. Ahlsén, J. Lindberg, H. O. Andersson, U. H. Danielson, B. Classon, T. Unge, B. Samuelsson, J. Hultén, A. Hallberg, A. Karlén, J. Med. Chem. 2001, 44, 155-169;
23. e) P.-O. Markgren, W. Schaal, M. Hämäläinen, A. Karlén, A. Hallberg, B. Samuelsson, U. H. Danielson, J. Med. Chem. 2002, 45, 5430-5439.
24. a) W. C. Groutas, R. Kuang, S. Ruan, J. B. Epp, R. Venkataraman, T. M. Truong, Bioorg. Med. Chem. 1998, 6, 661-671;
25. b) W. C. Groutas, N. M. Schechter, S. He, H. Yu, P. Huang, J. Tu, Bioorg. Med. Chem. Lett. 1999, 9, 2199-2204;
26. c) R. Kuang, J. B. Epp, S. Ruan, H. Yu, P. Huang, R. Venkataraman, S. He, J. Tu, N. M. Schechter, J. Turbov, C. J. Froelich, W. C. Groutas, J. Am. Chem. Soc. 1999, 121, 8128-8129;
27. d) R. Kuang, J. B. Epp, S. Ruan, L. S. Chong, R. Venkataraman, J. Tu, S. He, T. M. Truong, W. C. Groutas, Bioorg. Med. Chem. 2000, 8, 1005-1016.
28. J. L. Castro, R. Baker, A. R. Guiblin, S. C. Hobbs, M. R. Jenkins, M. G. N. Russell, M. S. Beer, J. A. Stanton, K. Scholey, R. J. Hargreaves, M. I. Graham, V. G. Matassa, J. Med. Chem. 1994, 37, 3023-3032.
29. M. J. Tozer, I. M. Buck, T. Cooke, S. B. Kalindjian, I. M. McDonald, M. J. Pether, K. I. M. Steel, Bioorg. Med. Chem. Lett. 1999, 9, 3103-3108.
30. a) K. H. Ahn, D. J. Yoo, J. S. Kim, Tetrahedron Lett. 1992, 33, 6661-6664;
31. b) S. V. Pansare, A. N. Rai, S. N. Kate, Synlett 1998, 623-624.
32. a) M. Preiss, Chem. Ber. 1978, 111, 1915-1921;
33. b) N. Aouf, G. Dewynter, J.-L. Montero, Tetrahedron Lett. 1991, 32, 6545-6546.
34. New methods for the synthesis of cyclosulfamides have been reported recently. For the synthesis of five-membered cyclosulfamides starting from amino acids, see: c) Z. Regaïnia, M. Abdaoui, N.-E. Aouf, G. Dewynter, J.-L. Montero, Tetrahedron 2000, 56, 381-387.
35. For the synthesis of nonsymmetrical sulfamides using Burgess-type reagents, see: d) K. C. Nicolaou, D. A. Longbottom, S. A. Snyder, A. Z. Nalbanadian, X. Huang, Angew. Chem. 2002, 114, 4022-4026; Angew. Chem. Int. Ed. 2002, 41, 3866-3870.
36. For the synthesis of nonsymmetrical sulfamides using Burgess-type reagents, see: d) K. C. Nicolaou, D. A. Longbottom, S. A. Snyder, A. Z. Nalbanadian, X. Huang, Angew. Chem. 2002, 114, 4022-4026; Angew. Chem. Int. Ed. 2002, 41, 3866-3870.
37. M. G. Organ, J. Wang, J. Org. Chem. 2002, 67, 7847-7851.
38. a) M. Montury, J. Goré, Synth. Commun. 1980, 10, 873-879;
39. b) C. J. Elsevier, J. Meijer, G. Tadema, P. M. Stehouwer, H. J. T. Bos, P. Vermeer, J. Org. Chem. 1982, 47, 2194-2196;
40. c) C. J. Elsevier, P. Vermeer, A. Gedanken, W. Runge, J. Org. Chem. 1985, 50, 364-367.
41. J.-Y. Winum, L. Toupet, V. Barragan, G. Dewynter, J.-L. Montero, Org. Lett. 2001, 3, 2241-2243.
42. N2′-type, intramolecular nucleophilic attack on the proximal carbon of the allene moiety.
43. We have already reported the formation of azetidines by NaH-mediated intramolecular animation of bromoallenes: see, ref. [2b].
44. To determine the intermediate of this tandem cyclization reaction, we investigated the stepwise reaction of the bromoallene 33. Treatment of the bromoallene 33 with NaH in DMF gave the pyrrolidine 37 in 86% yield. Reaction of 37 under the same reaction conditions as the one-pot reaction afforded the exo-cyclized product 34 (67%) and endo-cyclized product 35 (20%) in essentially the same product ratio. Related five-membered-ring formation by intramolecular amination of a carbon-carbon triple bond has been reported, see: a) Y. Tamaru, M. Kimura, S. Tanaka, S. Kure, Z. Yoshida, Bull. Chem. Soc. Jpn. 1994, 67, 2838-2849;
45. b) P. A. Jacobi, H. L. Brielmann, S. I. Hauck, J. Org. Chem. 1996, 61, 5013-5023;
46. c) M. M. Cid, D. (diagram presented) Domínguez, L. Castedo, E. M. Vázquez-López, Tetrahedron 1999, 55, 5599-5610.